Attorney General Conway Announces Key Rulings in Purdue Pharma Case

Unknown 2026 Healthcare / General
OIG Controlled Substance
Penalty
$0

Outcome

OIG enforcement action against Attorney General Conway Announces Key Rulings in Purdue Pharma Case for controlled substance.

Details

Attorney General Conway Announces Key Rulings in Purdue Pharma Case — OIG Enforcement (2026)

OIG took enforcement action against Attorney General Conway Announces Key Rulings in Purdue Pharma Case in 2026 involving controlled substance violations in the Healthcare / General sector.

Violation types: Controlled Substance
Entity type: Healthcare Provider
Penalty type: Settlement

Source: Attorney General Conway Announces Key Rulings in Purdue Pharma Case

How Crucible Prevents This

Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.

Source: Attorney General Conway Announces Key Rulings in Purdue Pharma Case

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works